No Data
Inspira Outline Transaction Framework for Breast Cancer Liquid Biopsy Expansion
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Inspira Technologies Announces Proposed Acquisition of Liquid Biopsy Diagnostics Business and $15 Million Strategic Equity Investment
Express News | Inspira Technologies: As Part of Acquisition, the Company Will Obtain a $15 Mln Equity Investment at a Company Pre-Money Valuation of $180 Mln
Express News | Inspira Technologies: Entered Into a Non-Binding Term Sheet With a Company to Acquire Liquid Biopsy Business
Press Release: Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation